Solventum: Q3 Earnings Snapshot

Solventum Corp. (SOLV) reported a Q3 loss of $12M, or 7 cents per share, but adjusted earnings of $1.45 per share beat estimates. Revenue was $1.95B, missing forecasts. The company expects full-year earnings of $7.20 to $7.30 per share.

Original reporting
Published Nov 5, 2026, 9:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 9:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Solventum: Q3 Earnings Snapshot — source image
Decision brief

The 30-second read

$SOLVBearishHigh
01

Why it matters

The earnings release provides fresh data on profitability and revenue, influencing short-term price action.

02

Market read

First report of Q3 earnings for SOLV, offering actionable insight for traders.

03

What to watch

Potential cost reductions or upcoming product launches not disclosed may mitigate revenue concerns.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

Solventum Corp. is a healthcare company with prior guidance expectations.

Company-level read

Ticker impact

$SOLVBearishHigh confidence
Context

Solventum Corp. reported Q3 loss of $12M and EPS of -$0.07, missing revenue expectations.

Expected impact

likely downside as market prices in revenue shortfall

Evidence & confidence

Revenue fell short of forecasts while adjusted EPS beat, creating mixed signals that typically weigh on price.

Market effects

Healthcare sector may see modest pressure if revenue miss signals broader demand concerns.

Limited to US-listed healthcare stocks.

Low global impact.

Counterpoint

Adjusted EPS beat could support a short-term rally if investors focus on profitability.

Key entities

  • Solventum Corp.

    Healthcare firm reporting Q3 results.

Related articles

$SOLVMedAI 8/10

SOLV Energy Q3 Revenue Rises 65% to $1.24 Billion; Raises 2026 Guidance

SOLV Energy reported Q3 2026 revenue of $1.24B, up 65% YoY, with net income of $123M. Adjusted EBITDA was $173M, and gross margin was 17.8%. The company raised its 2026 guidance for revenue, adjusted gross profit, and adjusted EBITDA. Growth was driven by new construction and existing infrastructure revenue. SOLV completed its acquisition of ASB Energy Services in October 2026.

$SOLVMed

Solventum (SOLV) stock trades up, here is why

Solventum (SOLV) shares rose 5% after reporting Q3 2026 revenue of $1.95B and EPS of $1.45, and raising full-year EPS guidance to $7.20-$7.30. The company completed ERP cutovers and exited 90% of transition agreements with 3M. Shares cooled to $91.19, up 4.6% from the previous close.

$SOLVMed

Solventum Q3 Earnings Call Highlights

Solventum reported Q3 sales of $1.9B, with mixed performance across segments. Gross margin rose to 57.1%, while operating margin fell to 19.9%. The company raised its full-year earnings outlook to $7.20-$7.30 per share and expects high-end organic sales growth. It also announced plans to separate its Health Information Systems business and renegotiated a raw material supply agreement with 3M.

MedAI 8/10

Solventum Earnings Call Signals Stronger Growth Ahead

Solventum Corporation (SOLV) reported Q3 earnings, highlighting strong execution despite ERP transition challenges. Sales were $1.95B, down 7% YoY, but organic growth was ~4% excluding ERP timing reversals. Gross margin rose to 57.1%, and full-year EPS guidance was raised to $7.20-$7.30. The 3M separation is 90% complete, with margin expansion and cost savings driving growth.